(Q46685517)

English

A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

0 references

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

intellectual disability

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

disability affecting intellectual abilities

1 reference

based on heuristic

inferred from title

Martin J Brodie

3

object named as

Martin J Brodie

0 references

author name string

Michael P Kerr

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

Gus A Baker

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

Martin J Brodie

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

publication date

2 September 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

Epilepsy Behavior

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

472-480

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

Epilepsy and intellectual disability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Learning disability and epilepsy. 1, towards common outcome measures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

An outcome audit at the epilepsy clinic: results from 1000 consecutive referrals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Beating the barriers: recruitment of people with intellectual disability to participate in research

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Topiramate in long-term treatment of epilepsy in the intellectually disabled

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Topiramate in patients with learning disability and refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

The Epilepsy Outcome Scale: the development of a measure for use with carers of people with epilepsy plus intellectual disability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.07.006

7 January 2021

Identifiers

10.1016/J.YEBEH.2005.07.006

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16140593

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46685517&oldid=2126812065"